Group 1 - The core point of the article is that China Shipbuilding Special Gas (中船特气) announced its board meeting and discussed the appointment of an accounting firm for the year 2025 [1] - The company's revenue composition for the year 2024 is as follows: integrated circuits account for 61.07%, display panels for 21.19%, pharmaceuticals for 7.75%, others for 4.77%, and chemical materials for 1.76% [1] - As of the report date, the market capitalization of China Shipbuilding Special Gas is 21.4 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, reveals that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]
中船特气:10月23日召开董事会会议